Arlington Trust Co LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 29.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,814 shares of the company’s stock after buying an additional 868 shares during the period. Arlington Trust Co LLC’s holdings in Colgate-Palmolive were worth $347,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chicago Partners Investment Group LLC raised its position in Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth about $602,000. Carrera Capital Advisors grew its holdings in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at about $4,066,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have weighed in on CL. JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Stock Performance
NYSE:CL opened at $86.81 on Monday. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $70.93 billion, a P/E ratio of 24.66, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The firm has a 50-day moving average price of $90.36 and a two-hundred day moving average price of $96.77. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business posted $0.87 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What is an Earnings Surprise?
- With Policy Shifts in Play, Are Crypto Stocks Worth Another Look?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Waste Management Stock Is a Top Defensive Play Now
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Defensive Energy Stocks to Hedge Against Trade Turmoil
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.